Phagomed SRL
Phagomed reported total assets of 8,901 € at the end of the 2025 financial year (annual accounts filed with the NBB on 10 Jun 2026).
The score of Phagomed shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Phagomed's annual accounts
| 2025 | |
|---|---|
| Net result | −1,261 € |
| Equity | 8,739 € |
| Cash | 3,009 € |
| EBITDA | −1,017 € |
| Total assets | 8,901 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 10 Jun 2026
Phagomed's financial analysis
- Solvency98.2%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Phagomed
Phagomed's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1016.131.715
- VAT number
- BE1016131715
- Peppol
- Registered · 0208:1016131715 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 12 Nov 2024
- Registered office
- 8870 Izegem
- Latest accounts
- 2025 · filed on 10 Jun 2026
- Activity
- Research and experimental development on other natural sciences and engineering (NACE 72109)
Phagomed (SRL) has been based in Izegem since 2024, active in: research and experimental development on other natural sciences and engineering. For 2025, it reports a net loss of 1,261 € and equity of 8,739 €; its revenue is not published. Its solvency stands at 98.2%, above the median of its sector (60.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Phagomed
Companies in the same business, of comparable size and area, outside its group.
- Alanine Research and experimental development on natural sciences and engineering Lasne · balance sheet 28,321 €
- IQVIA Cancer Research Research and experimental development on natural sciences and engineering Zaventem · balance sheet €1.07m
- Bimsconsult Research and experimental development on natural sciences and engineering Auderghem · balance sheet 463,296 €
- Indagen Research and experimental development on natural sciences and engineering Antwerp · balance sheet 10,059 €
- LAB.001 Research and experimental development on natural sciences and engineering Brussels · balance sheet 5,303 €
- Euraxi Research and experimental development on natural sciences and engineering Liège · balance sheet 15,180 €
- Evalchemist Research and experimental development on natural sciences and engineering Lasne · balance sheet 15,464 €
- Jacobs Consultancy Research and experimental development on natural sciences and engineering Antwerp · balance sheet 16,077 €
Frequently asked questions about Phagomed
What is the revenue of Phagomed?
Phagomed files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Phagomed?
In Belgium, the VAT number is the company number prefixed with BE: BE1016131715 for Phagomed, if the company is VAT-registered. Its company number (CBE) is 1016.131.715.
Where is the registered office of Phagomed?
According to the CBE register, the registered office of Phagomed is in 8870 Izegem.
What is the equity of Phagomed?
At the close of the 2025 financial year, the equity of Phagomed amounts to 8,739 €, a solvency of 98.2% of total assets.
Who manages Phagomed?
The register lists 4 active mandates at Phagomed. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Phagomed
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →